肝动脉栓塞联合无水乙醇注射治疗中晚期肝癌的效果观察

目的探讨肝动脉化疗栓塞(TAE)联合经皮穿刺乙醇注射(PEI)治疗中晚期肝癌的临床价值。方法分别对22例中晚期肝癌患者应用TAE+PEI治疗(治疗组),29例采用单纯TAE治疗(对照组),对两组患者治疗后的肿瘤大小、甲胎蛋白(AFP)的下降情况及生存率进行比较。结果治疗组肿瘤缩小明显,AFP下降率高于单纯TAE组(P均<0.05),患者的2年、3年生存率高于对照组(P均<0.05)。结论TAE+PEI联合治疗中晚期肝癌效果优于单纯TAE。

The efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma

Objective To study the efficacy of transcatheter arterial chemoembolization (TAE) combined with percutaneous ethanol injection (PEI) for the treatment of large hepatocellular carcinoma (HCC). Methods 22 patients were treated with TAE+PEI, while 29 patients received TAE alone. The following parameters: tumor size, AFP level and survival rate were evaluated. Results The rate of tumor minification and AFP renormaliztion rate in the TAE+PEI group were higher than those in the TAE alone group (all P<0.05). The 2～or3～year survival rate of the patients in the TAE+PEI group were higher than those in the TAE alone group (all P<0.05). Conclusion The therapeutic effect of TAE combined with PEI is much better than that of TAE alone.